Back to results
US 2026/0309722 A1Published application
Magnetic point-of-care systems and assays for determining gfap in biological samples
AssigneeAbbott Laboratories
InventorsAntti Virtanen, Cary James MILLER, Tony LEE, Peter KARABATSOS, Craig JEFFREY, Andrew SCHAPALS, Alison TAYLOR
Life of this patent
Estimating the term…
Abstract
Disclosed herein are systems and assays that employ magnetically susceptible beads and point-of-care devices comprising magnetic immunosensors to determine the amount of glial fibrillary acidic protein (GFAP) in a biological sample obtained from a subject.
Claims3
A cartridge comprising:
- a. a magnet;
- b. an area comprising printed paramagnetic particles coated with an anti-GFAP antibody;
- and
- c. an area comprising a plurality of printed detectably labeled anti-GFAP antibodies,
- wherein the cartridge is used in a point-of-care device.
2 more elements
Dependencies are inferred from the claim text.